{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05511246",
            "orgStudyIdInfo": {
                "id": "ADM00021434"
            },
            "organization": {
                "fullName": "The Methodist Hospital Research Institute",
                "class": "OTHER"
            },
            "briefTitle": "Venous Ethanol for Ventricular Tachycardia",
            "officialTitle": "Venous Ethanol for Ischemic Left Ventricular Tachycardia",
            "acronym": "VELVET",
            "therapeuticArea": [
                "Critical Care",
                "Cardiovascular"
            ],
            "study": "venous-ethanol-for-ventricular-tachycardia"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2023-04-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-12-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-08-08",
            "studyFirstSubmitQcDate": "2022-08-19",
            "studyFirstPostDateStruct": {
                "date": "2022-08-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "The Methodist Hospital Research Institute",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial",
            "detailedDescription": "Patients with ventricular tachycardia (VT) in the context of ischemic heart disease suffer from significant morbidity and mortality. Catheter ablation can improve outcomes but has suboptimal ablation results. Ethanol ablation via epicardial veins can add significant therapeutic value to catheter ablation by increasing reach to intramural VT substrates. Investigators will randomize patients with ischemic VT to either endocardial catheter ablation alone, or combined with venous ethanol (VE) ablation of coronary veins located on the epicardial aspect of the VT substrates. A combined primary endpoint: VT recurrence, procedural complications, hospitalization for cardiac causes, and death, will be measured over a 12-month follow-up."
        },
        "conditionsModule": {
            "conditions": [
                "Ventricular Tachycardia",
                "Ischemic Cardiomyopathy"
            ],
            "keywords": [
                "Ventricular tachycardia",
                "Coronary veins",
                "Ethanol",
                "Ablation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 156,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Control",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Endocardial radiofrequency ablation of ventricular tachycardia",
                    "interventionNames": [
                        "Procedure: Catheter ablation"
                    ]
                },
                {
                    "label": "Venous ethanol",
                    "type": "EXPERIMENTAL",
                    "description": "Endocardial radiofrequency ablation of ventricular tachycardia combined with venous ethanol ablation of the tachycardia substrate",
                    "interventionNames": [
                        "Drug: Venous ethanol",
                        "Procedure: Catheter ablation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Venous ethanol",
                    "description": "Cannulation of coronary vein or veins in the VT substrate and balloon injection of ethanol",
                    "armGroupLabels": [
                        "Venous ethanol"
                    ],
                    "otherNames": [
                        "Alcohol"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Catheter ablation",
                    "description": "Endocardial catheter ablation of VT substrate",
                    "armGroupLabels": [
                        "Control",
                        "Venous ethanol"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Ventricular tachycardia recurrence",
                    "description": "Detection of VT on defibrillator",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Hospitalization for cardiac causes",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Severe procedural complications",
                    "description": "Severe procedural complications include bleeding requiring transfusion, stroke or systemic embolization, pericardial tamponade, myocardial infarction, and vascular complications requiring surgery, plus cardiogenic shock requiring unplanned mechanical support.",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Death",
                    "timeFrame": "0-12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Procedural time",
                    "description": "Total procedure time (minutes)",
                    "timeFrame": "During procedure"
                },
                {
                    "measure": "Need for unplanned mechanical hemodynamic support",
                    "description": "Unplanned use of intra-aortic balloon pump or ventricular assist device during procedure (Yes/No)",
                    "timeFrame": "During procedure"
                },
                {
                    "measure": "Repeat ablation procedures, including epicardial",
                    "description": "Need for repeat procedure (Yes/No)",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "All-cause mortality",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Appropriate ICD therapies: antitachycardia pacing and ICD shocks",
                    "description": "Presence of appropriate ICD therapies on interrogation",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Inappropriate ICD therapies: antitachycardia pacing and ICD shocks",
                    "description": "Presence of inappropriate ICD therapies on interrogation",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Change in ICD therapies compared to 3-months pre-randomization",
                    "description": "Comparison of number of therapies on ICD interrogation",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Vt storm",
                    "description": "More than 2 episodes of VT within a 24h period",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Sustained VT below detection rate",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Change in left ventricular ejection fraction (percent)",
                    "description": "Measured before and 3 months after procedure",
                    "timeFrame": "Before and 3 months post-procedure"
                },
                {
                    "measure": "Quality of life measurement using SF-32 questionnaire",
                    "description": "Scores range from 0 - 100; Lower scores = more disability, higher scores = less disability",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Hospital admission for cardiac causes (including heart failure exacerbation)",
                    "description": "Hospitalization due to cardiac arrhythmia, heart failure exacerbation and other cardiac causes (yes/no)",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Antiarrhtyhmic therapy",
                    "description": "Number of antiarrhythmic drugs before and after ablation",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Freedom from VT after repeat procedures",
                    "description": "Recurrence of VT (yes/no) including patients that have multiple ablations",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Cardiac transplant or left ventricular assist device implantation",
                    "description": "As a measure of deterioration of cardiac status, requirement of transplant of ventricular assist device implant (yes/no) will be compared",
                    "timeFrame": "0-12 months"
                },
                {
                    "measure": "Fluoroscopy time",
                    "description": "Total time of fluoroscopy use (minutes)",
                    "timeFrame": "During procedure"
                },
                {
                    "measure": "Total contrast agent used",
                    "description": "Amount of radiographic contrast used (cc)",
                    "timeFrame": "During procedure"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male and female, ages of 18 and 85 years and with a prior ICD implant\n* Diagnosed with ischemic cardiomyopathy: Prior myocardial infarction (pathological Q waves or imaging evidence of regional myocardial akinesis/thinning in the absence of a non-ischemic cause)\n* One of the following VT events (within last 6 months): a) \u22653 episodes of VT treated with anti-tachycardia pacing (ATP) or anti-arrhythmic drugs; b) \u22651 appropriate ICD shocks; c) \u22653 VT episodes within 24 hr; d) sustained VT below detection rate of the ICD documented by EKG/cardiac monitor\n* Patients deemed candidates for RF ablation of VT\n* Able and willing to comply with pre-, post-, and follow-up requirements\n* Willing to sign the informed consent\n\nExclusion Criteria:\n\n* Serum creatinine \\>1.5 mg/dL, or creatinine clearance \\<30 ml/min\n* Left ventricular (LV) ejection fraction \u226410%\n* Mobile LV thrombus on echocardiography\n* Absence of vascular access to the LV\n* Disease process likely to limit survival to \\<12 months\n* New York Heart Association class IV heart failure\n* Cardiac surgery within the past 2 months (unless VT was incessant),\n* Acute coronary syndrome in the past 2 months (acute thrombus diagnosed by coronary angiography, or dynamic ST segment changes demonstrated on EKG)\n* Another reversible cause of VT (e.g. electrolyte abnormalities, drug-induced arrhythmia)\n* Severe aortic stenosis or mitral regurgitation with a flail leaflet\n* Pregnancy\n* Unwilling or unable to provide informed consent\n* Covid-19 positive testing within 14 days of randomization procedure\n* Enrolled, or planning to get enrolled, in another research study during his/her participation on the Velvet trial",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rene Plascencia",
                    "role": "CONTACT",
                    "phone": "7134416548",
                    "email": "rplascencia@houstonmethodist.org"
                },
                {
                    "name": "Casey Kappenman",
                    "role": "CONTACT",
                    "phone": "3462382367",
                    "email": "cjkappenman@houstonmethodist.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Miguel Valderrabano, MD",
                    "affiliation": "The Methodist Hospital Research Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Houston Methodist Hospital",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Chinwe Ngumezi, RN",
                            "role": "CONTACT",
                            "phone": "346-238-0290",
                            "email": "ccngumezi@houstonmethodist.org"
                        },
                        {
                            "name": "Rene Plascencia",
                            "role": "CONTACT",
                            "phone": "7134416548",
                            "email": "rplascencia@houstonmethodist.org"
                        },
                        {
                            "name": "Miguel Valderrabano, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009202",
                    "term": "Cardiomyopathies"
                },
                {
                    "id": "D000013610",
                    "term": "Tachycardia"
                },
                {
                    "id": "D000017180",
                    "term": "Tachycardia, Ventricular"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000001145",
                    "term": "Arrhythmias, Cardiac"
                },
                {
                    "id": "D000075224",
                    "term": "Cardiac Conduction System Disease"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10543",
                    "name": "Ischemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M16384",
                    "name": "Tachycardia",
                    "asFound": "Tachycardia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12154",
                    "name": "Cardiomyopathies",
                    "asFound": "Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19488",
                    "name": "Tachycardia, Ventricular",
                    "asFound": "Ventricular Tachycardia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M1472",
                    "name": "Cardiac Conduction System Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000431",
                    "term": "Ethanol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000891",
                    "term": "Anti-Infective Agents, Local"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "asFound": "Health education",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4215",
                    "name": "Anti-Infective Agents, Local",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}